Latest Australian Innovation News

Top End Energy has launched a Sponsored ADR program on the U.S. OTCQB market, enhancing its access to American investors and aligning its Kansas-based natural hydrogen project with U.S. energy independence goals.

dorsaVi has inked a five-year sales agreement with Select Medical, opening access to over 1,900 US outpatient physical therapy centers for its FDA-approved motion analysis products. This follows a successful 18-month pilot validating clinical benefits in athlete rehabilitation.

Acrux Limited has received a $3.04 million R&D Tax Incentive rebate for FY25 and fully repaid its short-term funding facility, underscoring its commitment to Australian pharmaceutical innovation.

Janus Electric has inked a $5 million Memorandum of Understanding with EVUNI to distribute its electric drivetrain technology across Africa, marking a bold step in its international growth strategy.

Papyrus Australia has signed a binding term sheet with TBS Mining Solutions to produce a biodegradable version of the Collar Keeper®, marking a major step in sustainable mining innovation.

Papyrus Australia has signed a binding term sheet with TBS Mining Solutions to produce a biodegradable version of the Collar Keeper®, marking a significant step in commercialising sustainable mining products.

Challenger Limited celebrates four decades with a robust 9% rise in net profit and a strategic digital transformation, positioning itself at the forefront of Australia’s retirement income market.

Tetratherix has landed a $3.3 million Australian Government grant to co-fund a $7.4 million project expanding its synthetic polymer production and supporting its US market entry in 2026.

Volt Group Limited (ASX – VPR) has initiated an on-market share buy-back of up to 5% of its issued capital, aligning with its capital management strategy as it advances commercialisation of its innovative zero-emission technologies.

CleanSpace Holdings reports a robust 26% increase in FY25 revenue, driven by strong growth across Europe, North America, and APAC regions, underscoring its expanding footprint in industrial respiratory protection.

Bio-Gene Technology Limited has raised $338,500 through a Share Purchase Plan, contributing to a total capital raise of $2.45 million to advance its bio-insecticide products.

Careteq Limited faces a significant repayment demand from the ATO over R&D tax claims but is mounting a formal objection backed by legal counsel.